Font Size:
a
A
A
Keyword [RRCL]
Result: 1 - 2 | Page: 1 of 1
1.
The Anticancer Activity Of Histone Deacetylase Inhibitor(IBH589) In Rituximab-resistant Raji Cell
2.
Acquired rituximab resistance is associated with cross -resistance to chemotherapy that is overcome by treatment with bortezomib
<<First
<Prev Next>
Last>>
Jump to